デフォルト表紙
市場調査レポート
商品コード
1536187

口腔がん治療の世界市場

Oral Cancer Treatment

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 279 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.05円
口腔がん治療の世界市場
出版日: 2024年08月16日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 279 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

口腔がん治療の世界市場は2030年までに25億米ドルに達する見込み

2023年に19億米ドルと推定される口腔がん治療の世界市場は、2023~2030年の分析期間においてCAGR 3.7%で成長し、2030年には25億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである化学療法は、CAGR 4.7%を記録し、分析期間終了までに12億米ドルに達すると予測されます。標的療法分野の成長率は、分析期間中CAGR 3.3%と推定されます。

米国市場は5億2,870万米ドルと推定、中国はCAGR 7.1%で成長予測

米国の口腔がん治療市場は、2023年に5億2,870万米ドルと推定されます。世界第2位の経済大国である中国は、2023-2030年のCAGRを7.1%として、2030年までに5億2,840万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.2%と2.8%と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界の口腔がん治療市場- 主要動向と促進要因のまとめ

口腔がんは、口腔、口唇、舌、頬、咽頭のがんを包含し、診断と治療の両面で大きな課題をもたらす世界の健康問題です。口腔がんの治療戦略は、腫瘍の病期や部位、患者の健康状態によって異なり、一般的には手術、放射線療法、化学療法が含まれます。手術は、機能をできるだけ温存しながらがん組織を切除することを目的とし、放射線療法は、高エネルギーの放射線を使ってがん細胞を狙い撃ちして死滅させるもので、化学療法は、がん細胞を破壊する薬剤を使用するもので、再発のリスクを減らすために他の治療法と併用されることが多いです。最近では、標的療法や免疫療法も導入され、正常細胞を傷つけることなくがん細胞を特異的に攻撃したり、がんと闘う免疫系の能力を高めたりすることで、新たな希望をもたらしています。

口腔がん治療へのアプローチは、医療技術の進歩や、疾患の根底にある分子メカニズムのより深い理解に影響され、近年大きく進化しています。プレシジョンメディシン(精密医療)が普及し、患者と腫瘍の遺伝子プロファイルに合わせた治療が行われるようになり、それによって治療効果が高まり、副作用が最小限に抑えられています。ロボット手術や強度変調放射線治療(IMRT)などの技術革新により、より精密で侵襲の少ない治療法が可能になり、患者の回復期間と治療成績が改善されています。さらに、新しい化学療法剤や生物学的製剤の開発により、利用可能な治療法の幅が広がっています。これらの治療に対する反応を予測できるバイオマーカーの同定に関する調査も続けられており、より個別化された効果的な管理戦略が促進されています。

口腔がん治療市場の成長は、タバコの使用やヒトパピローマウイルス(HPV)感染の増加が主な要因となり、世界中で口腔がんの発生率が上昇していることなど、いくつかの要因によって牽引されています。また、口腔がんに対する認識が高まり、早期発見と治療開始につながっています。強化された画像診断や分子診断などの診断技術の進歩により、診断の精度が向上し、治療効果のモニタリングが可能になり、市場はさらに拡大しています。さらに、より良い治療結果と副作用の少ない治療を患者が積極的に求めるという消費者行動の変化が、新しい治療法の開発に影響を与えています。世界のヘルスケア・インフラの拡充や新興国における医療支出の増加は、高度な治療へのアクセス拡大をもたらし、市場の成長に寄与しています。最後に、新規治療薬や治療方法に関する継続的な調査がこの分野の技術革新を後押ししており、将来的には口腔がんの管理が改善されることが期待されます。

調査対象企業の例(全86件)

  • AbbVie, Inc.
  • ALX Oncology, Inc.
  • AstraZeneca PLC
  • Exelixis, Inc.
  • Genentech, Inc.
  • GSK Plc
  • Iovance Biotherapeutics
  • Kura Oncology
  • Merck & Co., Inc.
  • NeoImmuneTech
  • Privo Technologies
  • Rakuten Medical
  • Regeneron Pharmaceuticals, Inc.
  • Sirnaomics, Inc.
  • Vaccinex Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26642

Global Oral Cancer Treatment Market to Reach US$2.5 Billion by 2030

The global market for Oral Cancer Treatment estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Targeted Therapy segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$528.7 Million While China is Forecast to Grow at 7.1% CAGR

The Oral Cancer Treatment market in the U.S. is estimated at US$528.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$528.4 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Oral Cancer Treatment Market - Key Trends and Drivers Summarized

Oral cancer, encompassing cancers of the mouth, lips, tongue, cheeks, and throat, is a significant global health concern that poses substantial challenges in terms of both diagnosis and treatment. Treatment strategies for oral cancer depend on the stage and location of the tumor, as well as the overall health of the patient, and typically include surgery, radiation therapy, and chemotherapy. Surgery aims to remove the cancerous tissue while preserving as much function as possible; radiation therapy uses high-energy rays to target and kill cancer cells; and chemotherapy involves the use of drugs to destroy cancer cells, often used in conjunction with other treatments to reduce the risk of recurrence. Recently, targeted therapy and immunotherapy have also been introduced, offering new hope by specifically attacking cancer cells without harming normal cells, or by boosting the immune system's ability to fight cancer.

The approach to oral cancer treatment has evolved significantly over recent years, influenced by advancements in medical technology and a better understanding of the molecular mechanisms underlying the disease. Precision medicine is becoming more prevalent, with treatments being tailored to the genetic profile of both the patient and the tumor, thereby enhancing the efficacy and minimizing the side effects. Technological innovations such as robotic surgery and intensity-modulated radiation therapy (IMRT) allow for more precise and less invasive treatment options, improving recovery times and outcomes for patients. Moreover, the development of new chemotherapeutic agents and biologic drugs are broadening the spectrum of available therapies. Research continues into the identification of biomarkers that can predict response to these treatments, facilitating more personalized and effective management strategies.

The growth in the oral cancer treatment market is driven by several factors, including the rising incidence of oral cancer worldwide, driven largely by increasing tobacco use and human papillomavirus (HPV) infections. There is also a growing awareness of the disease, leading to earlier detection and treatment initiation. Advances in diagnostic technologies, such as enhanced imaging and molecular diagnostics, are improving the precision of diagnosis and the monitoring of treatment response, further propelling the market. Additionally, changes in consumer behavior, with patients actively seeking out treatments that offer better outcomes and fewer side effects, are influencing the development of new therapies. The expansion of healthcare infrastructure globally and increased healthcare spending in emerging economies provide greater access to sophisticated treatments, contributing to market growth. Lastly, ongoing research into novel therapeutic agents and treatment modalities continues to drive innovation in the field, promising better management of oral cancer in the future.

Select Competitors (Total 86 Featured) -

  • AbbVie, Inc.
  • ALX Oncology, Inc.
  • AstraZeneca PLC
  • Exelixis, Inc.
  • Genentech, Inc.
  • GSK Plc
  • Iovance Biotherapeutics
  • Kura Oncology
  • Merck & Co., Inc.
  • NeoImmuneTech
  • Privo Technologies
  • Rakuten Medical
  • Regeneron Pharmaceuticals, Inc.
  • Sirnaomics, Inc.
  • Vaccinex Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Oral Cancer Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Tobacco and Smoking Addiction as Major Risk Factors Sets the Stage for Growth
    • Advances in Radiotherapy Propel Treatment Adoption
    • Increasing Focus on Early Diagnosis Strengthens Business Case for Oral Cancer Treatment
    • Expansion of Immunotherapy Spurs Market Adoption
    • Growing Awareness and Screening Programs Expands Addressable Market Opportunity
    • Increasing Adoption of Chemotherapy in Combination Therapies Propels Market Growth
    • Expansion of Health Insurance Coverage Strengthens Market Adoption
    • Increasing Availability of Advanced Diagnostic Tools Strengthens Market Dynamics
    • Government Funding and Support for Cancer Research Drives Market Growth
    • Rising Demand for Palliative Care Expands Market Reach
    • Growth of the Aging Population Sets the Stage for Market Expansion
    • Increasing Use of Artificial Intelligence in Treatment Planning Generates New Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Oral Cancer Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Oral Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Oral Cancer Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Oral Cancer Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Oral Cancer Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Oral Cancer Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION